Anti-Hemophilic Factor VIII Concentrate from China
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. As a blood fraction prepared for therapeutic uses, it falls under tariff item 3002.90.00 as 'Other' within the heading for human blood and immunological products.
Duty Rate — China → Canada
0%
Import Tips
• Ensure the product is labeled as a blood fraction for therapeutic use
• Provide CBSA with documentation of plasma origin and viral inactivation processes
• Verify any Health Canada licensing for blood products